Skip to main content

Peer Review reports

From: A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trial

Original Submission
25 Jan 2013 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
21 May 2013 Reviewed Reviewer Report - flora zagouri
25 Jun 2013 Author responded Author comments - Jose Baselga
Resubmission - Version 3
25 Jun 2013 Submitted Manuscript version 3
3 Jul 2013 Author responded Author comments - Jose Baselga
Resubmission - Version 4
3 Jul 2013 Submitted Manuscript version 4
Publishing
11 Jul 2013 Editorially accepted
22 Jul 2013 Article published 10.1186/1745-6215-14-228

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215